Concepedia

Wei Lou

WL

Statistics

Publications

76

Citations

5.5K

H-Index

45

Active since

1996

Affiliations

University of California, Davis(Current)

VA Northern California Health Care System

Roswell Park Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

Beijing Tongren Hospital

Wei Lou is an author at University of California, Davis specializing in oncology, prostate cancer, and medicine.

ORCID

Publications per year

1996–2024

76

Publications

76

Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Clinical Cancer Research · 2014 · 353 citations · Full text

, , +16

Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway

Wei Lou, Zuyao Ni, Kevin F. Dyer et al. · The Prostate · 2000 · 280 citations

, , +16

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Cancer Research · 2015 · 242 citations · Full text

, , +17

Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.

Soo Ok Lee, Wei Lou, Min Hou et al. · PubMed · 2003 · 187 citations

, , +17

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text

, , +17

1–5 of 76